Literature DB >> 6595642

Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.

J L Bos, M Verlaan-de Vries, A M Jansen, G H Veeneman, J H van Boom, A J van der Eb.   

Abstract

The activation of ras genes in naturally occurring tumors has, thus far, been found to be due to mutations in codon 12 or 61 resulting in single amino acid substitutions. We have used highly labeled synthetic oligonucleotides to detect mutations in these codons and to determine the exact position of the mutation. Using this approach we have found three different mutations in codon 61 of the N-ras gene of various human tumor cell lines. In the fibrosarcoma line HT1080 the first nucleotide of the codon is mutated; in the promyelocytic line HL60 the second and in the rhabdomyosarcoma line RD301 the third nucleotide. For RD301 this implies that the normal glutamine residue at position 61 is replaced by histidine. In addition to the mutated N-ras gene the three cell lines have a normal N-ras gene which is indicative of the dominant character of the mutations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6595642      PMCID: PMC320445          DOI: 10.1093/nar/12.23.9155

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  Hybridization of labeled RNA to DNA in agarose gels.

Authors:  T M Shinnick; E Lund; O Smithies; F R Blattner
Journal:  Nucleic Acids Res       Date:  1975-10       Impact factor: 16.971

2.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

3.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

4.  Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1.

Authors:  A Hall; C J Marshall; N K Spurr; R A Weiss
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

5.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.

Authors:  E Taparowsky; Y Suard; O Fasano; K Shimizu; M Goldfarb; M Wigler
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

6.  Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides.

Authors:  B J Conner; A A Reyes; C Morin; K Itakura; R L Teplitz; R B Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  High mutation frequency in DNA transfected into mammalian cells.

Authors:  M P Calos; J S Lebkowski; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Characterization of a human colon/lung carcinoma oncogene.

Authors:  M S McCoy; J J Toole; J M Cunningham; E H Chang; D R Lowy; R A Weinberg
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

9.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

10.  Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.

Authors:  A P Feinberg; B Vogelstein; M J Droller; S B Baylin; B D Nelkin
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

View more
  35 in total

1.  A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer.

Authors:  E Lopez-Crapez; H Bazin; E Andre; J Noletti; J Grenier; G Mathis
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 2.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

3.  Structure of the c-Ki-ras gene in a rat fibrosarcoma induced by 1,8-dinitropyrene.

Authors:  T Tahira; K Hayashi; M Ochiai; N Tsuchida; M Nagao; T Sugimura
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

Review 4.  The HL60 cell line: a model system for studying human myeloid cell differentiation.

Authors:  G D Birnie
Journal:  Br J Cancer Suppl       Date:  1988-12

5.  A Pro----Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen.

Authors:  M H Hofker; T Nukiwa; H M van Paassen; M Nelen; J A Kramps; E C Klasen; R R Frants; R G Crystal
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

6.  Gene expression of the chondroitin sulfate proteoglycan core protein PG19.

Authors:  M A Bourdon; M Shiga; E Ruoslahti
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

Review 7.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

8.  Genetic variants of human red-cell membrane sialoglycoprotein beta. Study of the alterations occurring in the sialoglycoprotein-beta gene.

Authors:  M J Tanner; S High; P G Martin; D J Anstee; P A Judson; T J Jones
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

9.  Concurrent mutations in two different ras genes in acute myelocytic leukemias.

Authors:  J W Janssen; J Lyons; A C Steenvoorden; H Seliger; C R Bartram
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

Review 10.  Therapeutic Approaches to RAS Mutation.

Authors:  Aaron J Scott; Christopher H Lieu; Wells A Messersmith
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.